Bellybutton Revision in Porto Alegre BR
Bellybutton Revision in Porto Alegre section, includes general infrmation about Bellybutton Revision Procedure, Bellybutton Revision Porto Alegre Local News, Bellybutton Revision Porto Alegre Surgeon Locator and other Bellybutton Revision related material.
Bellybutton Revision Procedure
Bellybutton Revision surgery, also known as Umbilicoplasty, is used to alter the look and shape of your bellybutton alone. The shape of your bellybutton is determined at birth, but may change over time due to weight changes, pregnancy, or an umbilical (bellybutton) hernia. Some people with minimal belly buttons or "outies" wish that they had more distinctive “innie” belly buttons, while other people dislike the shape of the navel. One may desire a "T" shape to the belly button, created by a tiny bit of overhanging abdominal skin over the top portion of the bellybutton or a horizontally shaped belly button to take on more of a vertical orientation. When a patient decides on Bell button Revision surgery as a solution to the problem, a meeting with the surgeon will determine how the belly button should look after surgery.
Bellybutton Revision surgery may be combined with other cosmetic surgery procedures, such as Liposuction, Tummy Tuck, and Breast Augmentation or done as an entirely separate procedure.
Bellybutton Revision, or Umbilicoplasty is performed with local anesthesia or conscious sedation by request of the patient. The procedure takes the average of 30 to 90 minutes. The surgery is usually performed in the doctor's office operating room, although a surgical facility may be used, especially if other procedures are performed simultaneously.
In the first 24 to 48 hours after your procedure you will notice very little swelling, bruising or discomfort. Most people return to work and normal activities either the same day or the day after the procedure. The healing process starts immediately.
The risks associated with Belly button Revision surgery are extremely rare. Though, like with all surgical procedures, there are some risks. As with any surgery, you can help reduce the risks by closely following the pre and post-surgery instructions provided to you by your surgeon. Possible risks include scarring, infections, under-correction or over-correction, or the need for further revisions. Incisions are typically hidden within the belly button and sutures are either dissolvable or removed in 7 to 10 days.
The results of Bellybutton Revision surgery are permanent except in cases of large weight gain or pregnancy after surgery.
The surgeon's fee can range from $500 to $2000. Bellybutton Revision surgery is considered cosmetic surgery, insurance does not apply.
Other Bellybutton Revision Procedures
All Body Procedures
Bellybutton Revision porto-alegre (current)
porto-alegre Buttock Augmentation
porto-alegre Calf Augmentation
porto-alegre Liposuction
porto-alegre Body Contouring
More Porto Alegre info...
Porto Alegre Understand
Porto Alegre is the state capital of Rio Grande do Sul and the biggest urban agglomeration of south Brazil. It is important to understand that the culture of the city isn't a "Brazilian culture", but almost an Argentinian or Uruguayan. These people are called "ga?chos", the same word that identify Argentina and Uruguay. So, this can be bad if you are searching for a typical Brazilian city, but it can be good if you speak Spanish, because the locals typically understand the language well. The perfect blend of Brazilian-Portuguese and Platinian-Spanish cultures, added to a strong European heritage gives the city a unique background within Brazil. The city is one of the richest metropolis in the country, the state capital with the highest life quality and literacy rate (97%), the book capital of Brazil, and is widely known in Brazil as the city with the most beautiful women in the country.
-
Plastic Surgery News...
- The FDA has accepted for review the licensing application for ustekinumab (CNTO 1275) for the treatment of chronic moderate to severe plaque psoriasis. Ustekinumab is a human monoclonal antibody that targets the cytokines interleukin-12 (IL-12) and interleukin-23 (IL-23), which are thought to be associated with some immune-mediated inflammatory disorders, including psoriasis. The submission is based on data from two phase III studies in nearly 2000 patients. The drug was filed for approval in the EU in December 2007 and is currently under review by the EMEA.
- A collaborative team of researchers spearheaded by Dennis Carson M.D., professor of medicine and director of the Rebecca and John Moores UCSD Cancer Center at the University of California, San Diego (UCSD) has identified a potent new anti-cancer drug isolated from a toxic blue-green algae found in the South Pacific.